Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of lacosamide as adjunctive therapy for uncontrolled primary generalized tonic-clonic seizures
jRCT2080223050Phase 3Completed
- Sponsor
- UCB
- Start
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in idiopathic epilepsy (IGE) and primary generalized tonic-clonic seizure (PGTCS), sponsored by UCB. Started Dec 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
idiopathic epilepsy (IGE)primary generalized tonic-clonic seizure (PGTCS)
Beyond the preview
Go deeper on jRCT2080223050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223050.